REAL

Glutathion s transferase π indicates chemotherapy resistance in breast cancer

Su, Fengxi and Hu, Xiaoqu and Jia, Weijuan and Gong, Chang and Song, Erwei and Hamar, Péter (2003) Glutathion s transferase π indicates chemotherapy resistance in breast cancer. Journal of Surgical Research, 113 (1). pp. 102-108. ISSN 00224804

[img] PDF
1009437.pdf
Restricted to Registered users only

Download (215Kb) | Request a copy

Abstract

Background. Breast cancer is the most common malignant disease of women. Pathologic response of breast cancer to chemotherapy has a great prognostic importance. Glutathion S Transferases (GSTs) might detoxify chemotherapeutic drugs within the cancer cells, thus contributing to chemotherapy resistance. The pi isoenzyme of GSTs seems to be of great relevance. Thus, we hypothesized that GSTpi expression in cancer biopsy can be a prognostic indicator for resistance to chemotherapy. To test this hypothesis, we evaluated before and after chemotherapy, tumor size, apoptosis of tumor cells with TUNEL assay, and proliferation of tumor cells by determining PCNA expression in biopsy samples, or in the surgically removed tumor tissue of GSTpi (-), and GSTpi (+) cases. Materials and methods. GSTpi immunoreactivity was determined in 42 female patients with breast cancer. Patients were divided into two groups according to the expression of GSTpi in the pre-treatment biopsy specimen: W (n = 22) and (n = 20) samples were analyzed. Surgery was performed 2 weeks after a single intravenous injection of the chemotherapeutic drugs [5-fluorouracil, adriamycin, mitomycin (FAM protocol)]. Results. Pre-chemotherapy values of tumor size, apoptosis, or proliferation did not differ between GSTpi (-) and (+) samples. Chemotherapy significantly inhibited tumor growth, and cell proliferation, and induced apoptosis in GSTpi (-) cases. However, these effects were significantly reduced in GSTpi (+) patients. Conclusion. These results suggest, that the presence of GSTpi in breast cancer tissue is a bad prognostic indicator, and these tumors are largely resistant to chemotherapy. Thus, GSTpi might be important in inactivating one or more of the chemotherapeutic agents used in this treatment. (C) 2003 Elsevier Inc. All rights reserved.

Item Type: Article
Subjects: Q Science / természettudomány > QR Microbiology / mikrobiológia > QR180 Immunology / immunológia
Depositing User: Erika Bilicsi
Date Deposited: 17 Oct 2012 14:11
Last Modified: 17 Oct 2012 14:11
URI: http://real.mtak.hu/id/eprint/3161

Actions (login required)

View Item View Item